STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
19 hedge funds and large institutions have $1.51M invested in Statera Biopharma, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$83.6K | |
| 2 | +$5.13K | |
| 3 | +$1.25K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$725 |
Top Sellers
| 1 | -$118K | |
| 2 | -$31K | |
| 3 | -$19.8K | |
| 4 |
BlackRock
New York
|
-$2.12K |
| 5 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
-$1K |